CONOCOPHILLIPS (COP)       115.62  +5.65 (+5.14%)

115.62  +5.65 (+5.14%)

US20825C1045 - Common Stock - After market: 115.63 +0.01 (+0.01%)


Fundamental Rating

7

We assign a fundamental rating of 7 out of 10 to COP. COP was compared to 377 industry peers in the Oil, Gas & Consumable Fuels industry. COP gets an excellent profitability rating and is at the same time showing great financial health properties. COP is not valued too expensively and it also shows a decent growth rate. With the nice dividend rating, COP could be a good candidate for dividend investing.




Profitability

Profitability Rating

8

COP has a Return On Assets of 16.98%. This is amongst the best returns in the industry. The industry average is 5.47%. COP outperforms 82% of its industry peers.
COP's Return On Equity of 31.69% is amongst the best of the industry. COP does better than the industry average Return On Equity of 24.39%.

The Piotroski-F score of COP is 8.00. This is a very strong score and indicates great health and profitability for COP.
COP has a Profit Margin of 24.34%. This is comparable to the industry average of 17.26%.
VS Industry

ROA (16.98%) VS Industry: 82% outperformed.

-63,651.82
767.41

ROE (31.69%) VS Industry: 66% outperformed.

0.26
5,310.48

Profit Margin (24.34%) VS Industry: 58% outperformed.

-57,028.57
296.15

Valuation

Valuation Rating

5

The Price/Earnings Ratio is 10.30, which indicates a very decent valuation of COP.
The Forward Price/Earnings Ratio of 8.67 indicates a rather cheap valuation of COP.
The low PEG Ratio, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
When comparing the current price to the book value of COP, we can conclude it is valued correctly. It is trading at 2.93 times its book value.

Compared to an average industry Enterprise Value to EBITDA ratio of 4.74, COP is valued in line with its industry peers.
Compared to an average industry Price/Earning Ratio of 7.64, COP is valued slightly more expensive.
When comparing the price book ratio of COP to the average industry price book ratio of 1.81, COP is valued more expensive than its industry peers.
VS Industry

Price/Earnings (10.3) VS Industry: 35% outperformed.

1,065.00
0.04

Price/Book (2.93) VS Industry: 29% outperformed.

2,531.47
0.02

Enterprise Value/ EBITDA (4.86) VS Industry: 49% outperformed.

2,584.37
0.04

Growth

Growth Rating

6

The Earnings Per Share has grown by an impressive 668.49% over the past year.
COP shows a strong growth in Earnings Per Share. Measured over the last 5 years, the EPS has been growing by 69.32% yearly.
The Revenue has grown by 123.42% in the past year. This is a very strong growth!
COP shows quite a strong growth in Revenue. Measured over the last 5 years, the Revenue has been growing by 13.67% yearly.

COP is expected to show a small growth in Earnings Per Share. In the coming 5 years, the EPS will grow by 5.03% yearly.
The Revenue is expected to grow by 0.55% on average over the next 5 years.
When comparing the EPS growth rate of the last years to the growth rate of the upcoming 5 years, we see that the growth is decreasing.
The Revenue growth is decreasing: in the next 5 years the growth will be less than in the last years.

PastFuture
5Y3Y1Y1Y2Y3Y5Y
EPS69.32% 9.74% 668.49% 157.56% 49.08% 22.16% 5.03%
Revenue13.67% 7.84% 123.42% 79.43% 21.09% 10.85% 0.55%

Health

Health Rating

8

COP is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.16.
COP is better placed than average in its industry to meet its short term obligations. Its Current Ratio is much better than the industry average of 1.02.
COP has an Altman-Z score of 4.09. This indicates that COP is financially healthy and little risk of bankruptcy at the moment.
COP is in better financial health than average in its industry. Its Altman-Z score is much better than the industry average of 2.00.

COP has a very good Piotroski-F score of 8.00. This indicates a great health and profitability for COP.
A Current Ratio of 1.54 indicates that COP should not have too much problems paying its short term obligations.
A Quick Ratio of 1.44 indicates that COP should not have too much problems paying its short term obligations.
The Debt to Equity ratio of COP is in line with the industry averages.
VS Industry

Debt/Equity (0.32) VS Industry: 47% outperformed.

150.19
0.00

Quick Ratio (1.44) VS Industry: 65% outperformed.

0.00
295.99

Current Ratio (1.54) VS Industry: 64% outperformed.

0.00
295.99

Altman-Z (4.09) VS Industry: 77% outperformed.

-110,323.97
1,587.26

Dividend

Dividend Rating

9

COP has a Yearly Dividend Yield of 4.41%, which is a nice return.
Compared to an average S&P500 Dividend Yield of 2.63, COP pays a better dividend.
On average, the dividend of COP grows each year by 19.51%, which is quite nice.
COP's earnings are growing more than its dividend. This makes the dividend growth sustainable.

19.11% of the earnings are spent on dividend by COP. This is a low number and sustainable payout ratio.
COP has been paying a dividend for at least 10 years, so it has a reliable track record.
COP's Dividend Yield is comparable with the industry average which is at 5.18.
VS Industry

Dividend Yield (4.41%) VS Industry: 43% outperformed.

0.35
54.35
COP Daily chart

CONOCOPHILLIPS115.62

NYSE:COP (10/4/2022, 7:19:04 PM)+5.65 (+5.14%)

After market: 115.63 +0.01 (+0.01%)

Chartmill FA Rating
GICS Sector Energy
GICS IndustryGroup Energy
GICS Industry Oil, Gas & Consumable Fuels
Earnings (Last) 08-04 2022-08-04/bmo Earnings (Next) 10-31 2022-10-31
Ins Owners 0.08% Inst Owners 80.66%
Market Cap 147.19B Analysts 82.5
Valuation
PE 10.3 Fwd PE 8.67
PEG (NY) 0.07 PEG (5Y) 0.15
P/S 2.25 P/B 2.93
EV/EBITDA 4.86
Dividend
Dividend Yield 4.41% Dividend Growth 19.51%
DP 19.11% Ex-Date 09-29 2022-09-29 (1.4)
Growth
EPS 1Y 668.49% EPS 3Y 9.74%
EPS 5Y 69.32% EPS growth Q2Q 207.87%
EPS Next Y 157.56% EPS Next 2Y 49.08%
EPS Next 3Y 22.16% EPS Next 5Y 5.03%
Revenue growth 1Y 123.42% Revenue growth 3Y 7.84%
Revenue growth 5Y 13.67% Revenue growth Q2Q 121.44%
Revenue Next Year 79.43% Revenue Next 2Y 21.09%
Revenue Next 3Y 10.85% Revenue Next 5Y 0.55%
Health
Current Ratio 1.54 Quick Ratio 1.44
Altman-Z 4.09 F-Score 8
Debt/Equity 0.32 WACC 12.95%
ROIC/WACC 1.3
Profitability
ROA 16.98% ROE 31.69%
ROIC 16.81% ROICg 16.81%
PM 24.34% OM 32.98%
Asset Turnover 0.7

Fundamental Stock Screener Links

Screen Image

Fundamental Stock Screener

Find stocks with similar Fundamental rating on the USA

Screen Image

Best Fundamental Competitors Stock Screener

Find the competitors with the best fundamentals on the USA

Screen Image

Best Valuation Competitors Stock Screener

Find the competitors with the best valuation on the USA

Screen Image

Best Dividend Competitors Stock Screener

Find the competitors with the best dividend on the USA